eMedicine Specialties > Emergency Medicine > Trauma & Orthopedics
Knee Injury, Soft Tissue: Treatment & Medication
Updated: Dec 15, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Treatment
Prehospital Care
- Basic responsibilities in the prehospital setting, if knee trauma is the primary injury, include stabilizing the lower extremity and monitoring the neurovascular status of the limb.
- The deformed knee should be realigned only if associated neurovascular structures are compromised.
- Always recheck and document pulses after splinting or manipulation of the limb.
- If initial efforts meet with resistance, prehospital personnel should not force realignment.
- Cover open wounds with saline-soaked sterile gauze.
- Frequently, the joint reduces spontaneously or is reduced at the scene by trained emergency medical services (EMS) personnel; in such cases, the ED physician must obtain information about the time and mechanism of injury and the original position of the limb.
Emergency Department Care
Adhere to the conventional dictums of emergency and trauma care by first corroborating the absence of life-threatening (primary survey) or limb-threatening (secondary survey) injuries before focusing on soft-tissue damage sustained by the knee. A cardinal error occurs when earliest attention is diverted to an obvious extremity injury, such as a knee dislocation, while neglecting possibly lethal trauma.
- Always determine the mechanism of injury and verify hemodynamic stability.
- Assess vascular perfusion and control any bleeding.
- Hard signs of vascular injury include absent or diminished pulses, active hemorrhage, and expanding or pulsatile hematoma.
- Signs of distal ischemia include pain out of proportion to the injury, pallor, paralysis, and paresthesias.
- For knee dislocations or grossly malaligned fractures with potential vascular compromise, attempt immediate reduction or realignment of the knee if an orthopedic specialist is not immediately available.
- Popliteal-artery injuries must be repaired within 6-8 hours to avoid amputation because of limb ischemia.
- Splint all obvious fractures and unstable knee injuries, stabilizing the femur above and the tibia below.
- Damage to essential nerves and vessels may be subtle on presentation.
- Observe for signs and symptoms of compartment syndrome. Measurement of compartment pressures is often needed to exclude the possibility of compartment syndrome.
- Remove any constricting clothes and bandages.
- Make sure patients ingest nothing by mouth (NPO) until the need for emergency or urgent surgery is ascertained.
- General treatment principles include the following:
- Aside from the particular injury, treatment plans depend on the patient's age and activity level and the presence of additional injuries.
- Obtain orthopedic consultation when appropriate.
- Initial nonpharmaceutical treatment includes rest, ice, compression, and elevation (RICE).
- For the first 1-3 days, use therapeutic measures that minimize incipient damage and reduce pain and inflammation.
- Consider splinting the injured knee to provide support and to prevent further injury.
- Serviceable devices include commercially available immobilizers and handcrafted compressive dressings, such as the Robert Jones dressing, which incorporates coaptation plaster.
- Detrimental effects of immobilization include joint stiffness, degenerative changes in articular cartilage, muscle atrophy and weakness, and decreased vascularity.
- Therapy for specific injuries include the following:
- For first-degree sprains, provide symptomatic treatment, essentially the RICE regimen. Normal function usually returns quickly.
- Second-degree sprains require protection by using a cast, cast brace, or a restrictive movement brace. Arrange for timely follow-up care.
- Treatment of third-degree sprains depends on the severity and type of instability; some third-degree sprains of ligaments necessitate surgical repair. Factoring into the deliberation for surgery is the patient's age, relative health, associated injuries, activity demands, and individual desires.
- Treatment for anterior cruciate ligament (ACL) injuries is individualized. Various conditions influence decisions on the optimum management of ACL tears, such as the presence or absence of comorbid pathology, age of the patient, baseline activity level, degree of instability, and associated ligamentous injuries miring the knee.
- Presence of a meniscal tear does not automatically lead to surgical intervention. If the knee is not locked or unstable, conventional treatment (ie, RICE therapy) ordinarily suffices; however, the meniscus cartilage of the knee generally supports a precarious blood supply, and tears are prone to inadequate mending. Therefore, timely follow-up care is critical.
- Emergency consultation with an orthopedic specialist is required for immediate reduction and evaluation of vascular integrity after a knee dislocation. If expedient orthopedic consultation is not obtainable and if signs of vascular compromise are present, the ED physician should undertake maneuvers to restore both integrity of the joint and perfusion. (See Dislocations, Knee for specific reduction techniques.) Angiography is imperative.
- Reduction of knee dislocation includes the following:
- Most knee dislocations reduce spontaneously before the patient's arrival in the ED. However, when examination findings suggest neurovascular compromise, an attempt to restore circulation with traction and/or reduction and emergency orthopedic consultation are needed.
- Classify dislocations with respect to the relationship of the tibia on the femur.
- Anterior dislocations occur most commonly.
- In the ideal case, perform reductions in the operating room under general anesthesia. However, if circumstances preclude this scenario, an attempt in the ED is warranted.
- Barring contraindications, administer conscious sedation.
- With an assistant providing stabilization and countertraction of the thigh, a second person applies longitudinal traction to the leg. This maneuver usually suffices for reduction.
- Reduction of an anterior knee dislocation may be aided by trying to transpose the femur anteriorly.
- Avoid affixing pressure over the popliteal space as it may exacerbate arterial damage.
- For posterior dislocations (where the tibia lies posterior to the femur), attempt to reinstate the tibia anteriorly by gently lifting the tibia forward.
- After relocation of the knee, confirm neurovascular status and immobilize the knee in 15° of flexion.
- Order postreduction images and consultation with the orthopedic surgeon, and obtain an emergency arteriogram.
- Reduction of patellar dislocation includes the following:
- Patellar dislocations typically occur in predisposed individuals and tend to recur.
- Patellar dislocations are identified with respect to the patella's position on the knee joint, with lateral dislocations being most common.
- If the joint has not already reduced spontaneously, verify the dislocation radiographically.
- After administering necessary analgesia, place the hip in a mild amount of flexion, and gently press anteriorly and medially on the patella while extending the knee joint.
- Postreduction films should include a sunrise view, as osteochondral fractures may result.
- Other types of patellar dislocations tend to be resistant to closed reduction.
- Aspiration of a Baker cyst may render temporizing relief. This procedure is best performed electively by a qualified physician.
- Injection therapy
- Ensure that the joint is not infected.
- Pain secondary to aseptic inflammation of the prepatellar, suprapatellar, and pes anserine bursae may be relieved by instilling 2-4 mL of lidocaine mixed with 15-20 mg of a prednisolone suspension into the affected bursae.
- Recent data have suggested that an intra-articular installation of morphine 1-5 mg confirms a local analgesic effect and possibly prolongs pain relief compared with systemic opioids.
- Reducing the locked knee
- Avoid undue manipulation because it may aggravate internal derangement.
- A simple measure to reduce the locked knee involves positioning the patient with the knee dangling over the edge of the examination table in 90° of flexion.
- Gravity usually expedites distraction of the tibia from the femur, thereby promoting unlocking.
- If this technique fails after a reasonable time period, tempered rotation of the knee along with caution traction on the leg usually frees the knee joint.
Consultations
Depending on the degree of knee instability, affected ligaments, and the patient's age and baseline activity level, early surgical intervention may be the best option.
- Indications for emergency or urgent orthopedic consultation include the following:
- Gross knee dislocation or unstable knee
- All knee injuries with associated neurologic or vascular injury
- Complete quadriceps tendon rupture or a complete patellar tendon rupture
- First-time patellar dislocations and patellar displacements accompanied by an osteochondral fracture
- Open joint injuries of the knee
Medication
In addition to resolving the etiology of the knee pain, the ED physician must make every effort to relieve suffering as completely and expeditiously as possible. Distinguish acute injury from chronic distress. Consider the intensity of the pain. The perception of pain is subjective, and therapy should be individualized.
Objective parameters, such as tachycardia, are unreliable. Minor trauma to the knee that involves the ligaments, muscles, and joints usually causes a mild to moderately severe, self-limiting discomfort. An enormous choice of analgesics is available for use by the ED physician, but pharmacologic agents tend to fall into 2 general categories: nonnarcotic and narcotic analgesics. Furthermore, consider the best route for delivering the drug.
Nonnarcotic analgesics
Patients with pain accompanying minor acute soft-tissue injuries of the knee generally benefit from a short course of nonnarcotic analgesics, with acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) being the most frequently prescribed agents. If inflammation is a component of the injury and if no contraindication is present, prescribe NSAIDs, as acetaminophen lacks anti-inflammatory properties. An increasing number of NSAIDs are available for use. NSAIDs share a common mechanism of action, which involves inhibiting the production of pain-mediating prostaglandins. In general, NSAIDs provide a comparable degree of pain and inflammatory relief, but they differ in dosing schedules.
Choosing an NSAID to prescribe can be perplexing; data comparing these agents are meager, and individual responses are inconsistent. Because no individual NSAID is clearly superior, base decisions on personal experience, safety profiles, cost, and convenience.
Acetaminophen (Tylenol, Feverall, Aspirin Free Anacin)
Most commonly ingested pain reliever; marketed in combination with other drugs to provide analgesia. Advantages include availability, cost, and relatively good safety profile. Onset of relief usually in 20-30 min. Extended-release preparations do not appear to offer major benefits (other than dosing convenience) and may increase incidence of toxicity. For children, available as drops (80 mg/0.8 mL), elixir (160 mg/5 mL), tablets (80, 160, or 325 mg), and suppositories (125 or 325 mg).
Adult
650-1000 mg PO q4h; not to exceed 4000 mg/d PO
Pediatric
10-15 mg/kg/dose PO q4-6h
Rifampin can reduce analgesic effects; barbiturates, carbamazepine, alcohol, hydantoins, zidovudine, and isoniazid may increase hepatotoxicity
Documented hypersensitivity; known G-6-P deficiency
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
Hepatotoxicity possible in chronic alcoholism following various dose levels; severe or recurrent pain or high or continued fever may indicate serious illness; many over-the-counter (OTC) products contain acetaminophen, and combined use may result in cumulative doses exceeding recommended maximum
Acetylsalicylic acid (Bayer Aspirin, Bufferin, Anacin, Ecotrin)
Prototype NSAID; used in combination with many other drugs; available OTC. Offers anti-inflammatory benefits, unlike acetaminophen. Effective in PO, suppository, and topical preparations. Therapeutic anti-inflammatory serum level 15-30 mg/dL.
Adult
650 mg PO q4-6h
Pediatric
10-15 mg/kg/dose PO q 4-6h
Effects may decrease with antacids and urinary alkalinizers; corticosteroids decrease serum levels; additive hypoprothrombinemic effects and increased bleeding time may occur with anticoagulants; may antagonize uricosuric effects of probenecid and increase toxicity of phenytoin and valproic acid; doses >2 g/d may potentiate glucose-lowering effect of sulfonylurea drugs
Documented hypersensitivity; liver damage; hypoprothrombinemia; vitamin K deficiency; bleeding disorders; asthma; because of association with Reye syndrome, do not use in children (<16 y) with flu
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Precautions
May cause transient decrease in renal function and aggravate chronic kidney disease; avoid use in patients with severe anemia, with history of blood coagulation defects, or taking anticoagulants
Ketorolac (Toradol)
Choice of parenteral pain medications dispensed in ED. Frequently overlooked fact is that this medication is an NSAID, with all of the group's attendant risks and that it costs almost 20 times more than morphine (and 140 times more than ibuprofen). Data supporting superiority over other analgesics scarce.
Adult
10 mg PO q6h prn
15-30 mg IV/IM q6h prn; administer IV dose over 15-30 sec; not to exceed 5 d of treatment
Pediatric
<16 years: Not established
>16 years: Administer as in adults
Aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and possibly toxicity; may decrease effects of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase prothrombin time (PT) in patients taking anticoagulants; monitor PT closely, and instruct patients to watch for signs of bleeding; may increase risk of methotrexate toxicity; may increase phenytoin levels
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding; do not administer into CNS
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Precautions
Acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; low WBC counts (rare) usually return to normal during ongoing therapy; discontinue therapy if persistent leukopenia, granulocytopenia, or thrombocytopenia occur
Ibuprofen (Motrin, Advil, Nuprin)
Widely used NSAID, also available OTC, derivative of propionic class of NSAIDs and considered safest of NSAIDs. Available as tablets 200, 400, 600, and 800 mg; pediatric dosage forms available as tab and PO suspension (20 mg/mL). Advise taking with food or milk if possible; caution in children with flulike illnesses.
Adult
400-600 mg PO q6h or to 800 mg PO q8h
Pediatric
30-50 mg/kg/d PO divided qid; not to exceed 2400 mg/d
Aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and possibly toxicity; may decrease effects of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT in patients taking anticoagulants; monitor PT closely, and instruct patients to watch for signs of bleeding; may increase risk of methotrexate toxicity; may increase phenytoin levels
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Precautions
Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in coagulation abnormalities or during anticoagulant therapy
Narcotic analgesics
Patients reporting inadequate pain relief from NSAIDs may benefit from short-term supplementation with an opioid compound. A wide array of products is available. PO hydrocodone (Lortab, Lorcet, Vicodin, Anexsia), schedule III narcotic, and oxycodone (Roxicet, Percodan, Tylox), schedule II substance, usually provide additional pain relief. Codeine-containing products (schedule III) are not as reliable for alleviating pain. Although relative potencies of oxycodone and hydrocodone are approximately 0.33 of those with parenteral morphine, PO codeine is 0.05. Mixed agonist-antagonist PO agents (eg, butorphanol, nalbuphine, pentazocine), offer no real advantages to opioid agents yet increase incidence of adverse effects. Common adverse effects include constipation, nausea, respiratory depression, sedation, and urinary retention.
General approved dosage of hydrocodone is 5-10 mg combined with acetaminophen 500-750 mg administered PO q6h prn. Oxycodone analgesic preparations typically combine 2.5-5 mg of oxycodone with 325 mg of acetaminophen, dosed as 1-2 tabs PO q4h prn for moderate to severe pain. Acetaminophen with codeine (Tylenol #3) contains 30 mg of codeine with 325 mg of acetaminophen. Usually, 1-2 pills q4h prn is recommended.
Elixirs containing hydrocodone (Hycodan) are convenient for children older than 6 years with moderately severe to severe pain and who are unable to swallow pills. One teaspoon (5 mL) of Hycodan contains 5 mg of hydrocodone, with 1.25-2.5 mg administered q4h, depending on the child's size and severity of pain. The elixir of Tylenol with codeine for children contains 120 mg of acetaminophen and 12 mg/5 mL of codeine in an alcohol base (7%).
Orally administered drugs generally impart a slower onset of action. For patients in severe pain or for those patients who must be kept NPO, parenteral agents may be necessary. Although the IM route may be more convenient for the staff, the IV route offers a number of advantages. Narcotics administered IV provide a rapid and predictable onset of action and are easier to titrate. Morphine and meperidine are the most commonly used parenteral narcotic agents.
Hydrocodone and acetaminophen (Vicodin, Lorcet, Lortab, Anexsia)
Drug combination indicated for relief of moderately severe to severe pain.
Adult
1-2 tab or cap PO q4-6h prn
Pediatric
<12 years: 10-15 mg/kg/dose of acetaminophen PO q4-6h prn; not to exceed 2.6 g/d of acetaminophen
>12 years: 750 mg of acetaminophen PO q4h
Single dose not to exceed 10 mg of hydrocodone bitartrate; do not exceed 5 doses in 24 h
Phenothiazines may decrease analgesic effects; CNS depressants or tricyclic antidepressants increase toxicity
Documented hypersensitivity; elevated intracranial pressure
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
Tablets contain metabisulfite, which may cause hypersensitivity; caution in patients dependent on opiates because substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction
Oxycodone and acetaminophen (Percocet, Tylox, Roxicet)
Drug combination indicated for relief of moderately severe to severe pain.
Adult
1-2 tab or cap PO q4-6h prn
Pediatric
0.05-0.15 mg/kg/dose oxycodone PO q4-6h prn; not to exceed 5 mg/dose of oxycodone
Phenothiazines may decrease analgesic effects; CNS depressants or tricyclic antidepressants increase toxicity
Documented hypersensitivity
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Duration of action may increase in elderly persons; be aware of total daily dose of acetaminophen patient is receiving; do not exceed 4000 mg/24 h of acetaminophen; higher doses may cause liver toxicity
Acetaminophen and codeine (Tylenol #3)
Drug combination indicated for treatment of mild to moderately severe pain.
Adult
30-60 mg/dose (based on codeine content) PO q4-6h or 1-2 tab q4h; not to exceed 12 tabs/d
Pediatric
0.5-1 mg/kg/dose (based on codeine content) PO; 10-15 mg/kg/dose q4h (based on acetaminophen content); not to exceed 2.6 g/d
CNS depressants or tricyclic antidepressants increase toxicity
Documented hypersensitivity
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Caution in patients dependent on opiates (substitution may result in acute opiate-withdrawal symptoms); caution in severe renal or hepatic dysfunction
Morphine sulfate (Oramorph, MS Contin, Duramorph)
Criterion standard for relief of acute severe pain; may be administered in a number of ways; commonly titrated until desired effect obtained. IV morphine demonstrates half-life of 2-3 h; however, half-life may be 50% longer in the elderly.
Adult
Loading dose: 0.1 mg/kg IV/IM/SC
Maintenance dose: 5-20 mg/70 kg IV/IM/SC q4h
Relatively hypovolemic patients: Start with 2 mg IV/IM/SC and reassess hemodynamic effects of dose
Pediatric
0.11-0.2 mg/kg/dose IV; then titrate carefully to adequate pain relief
Phenothiazines may antagonize analgesic effects; tricyclic antidepressants, MAOIs, and other CNS depressants may potentiate adverse effects
Documented hypersensitivity; hypotension; potentially compromised airway in which establishing rapid airway control would be difficult
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Avoid in hypotension, respiratory depression, nausea, emesis, constipation, and urinary retention; caution in atrial flutter and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate
Meperidine (Demerol)
Narcotic analgesic with multiple actions similar to morphine; however, may cause less constipation, smooth muscle spasm, and depression of cough reflex than similar analgesic doses of morphine. Serum half-life 2 h. Metabolism occurs by hepatic demethylation into normeperidine. Patients with moderately severe to severe liver disease may develop excessive levels of metabolites, precipitating CNS adverse effects, including tremors and seizures.
Adult
50 mg PO/IV/IM/SC initially; then, titrate up to 150 mg
Pediatric
0.5-1 mg/kg/dose PO/IV/IM/SC; not to exceed 150 mg
Monitor for increased respiratory and CNS depression with coadministration of cimetidine; hydantoins may decrease effects; avoid with protease inhibitors
Documented hypersensitivity; concurrent MAOIs; upper airway obstruction or significant respiratory depression; during labor when delivery of premature infant anticipated
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Caution in patients with head injuries since meperidine may increase respiratory depression and CSF pressure (use only if absolutely necessary); caution when using postoperatively and with history of pulmonary disease (suppresses cough reflex)
Substantially increased dose levels given because of tolerance may aggravate or cause seizures even if no history of convulsive disorders; monitor closely for meperidine-induced seizure activity if prior seizure history
More on Knee Injury, Soft Tissue |
| Overview: Knee Injury, Soft Tissue |
| Differential Diagnoses & Workup: Knee Injury, Soft Tissue |
Treatment & Medication: Knee Injury, Soft Tissue |
| Follow-up: Knee Injury, Soft Tissue |
| Multimedia: Knee Injury, Soft Tissue |
| References |
| « Previous Page | Next Page » |
References
Kapur S, Wissman RD, Robertson M, et al. Acute knee dislocation: review of an elusive entity. Curr Probl Diagn Radiol. Nov-Dec 2009;38(6):237-50. [Medline].
Shah MK. Simultaneous bilateral rupture of quadriceps tendons: analysis of risk factors and associations. South Med J. Aug 2002;95(8):860-6. [Medline].
[Guideline] Pavlov H, Saboeiro GR, Campbell SE, Dalinka MK, Daffner RH, DeSmet AA, El-Khoury GY, Kneeland JB, Manaster BJ, Morrison WB, Rubin DA, Schneider R, Steinbach LS, Weissman BN, Haralson RH III, Expert Panel on Musculoskeletal Imaging. Acute trauma to the knee. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. [Full Text].
Shaerf D, Banerjee A. Assessment and management of posttraumatic haemarthrosis of the knee. Br J Hosp Med (Lond). Aug 2008;69(8):459-60, 462-3. [Medline].
Akseki D, Ozcan O, Boya H, Pinar H. A new weight-bearing meniscal test and a comparison with McMurray's test and joint line tenderness. Arthroscopy. Nov 2004;20(9):951-8. [Medline].
Andersen RE, Crespo CJ, Ling SM, Bathon JM, Bartlett SJ. Prevalence of significant knee pain among older Americans: results from the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. Dec 1999;47(12):1435-8. [Medline].
Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ. Apr 10 2004;328(7444):869. [Medline].
Bachmann LM, Haberzeth S, Steurer J, ter Riet G. The accuracy of the Ottawa knee rule to rule out knee fractures: a systematic review. Ann Intern Med. Jan 20 2004;140(2):121-4. [Medline].
Bahk MS, Cosgarea AJ. Physical examination and imaging of the lateral collateral ligament and posterolateral corner of the knee. Sports Med Arthrosc. Mar 2006;14(1):12-9. [Medline].
Berfeld J, Ireland ML, Wojtys EM. Pinpointing the cause of acute knee pain. Patient Care. 1997;31(18):100-117.
Calmbach WL, Hutchens M. Evaluation of patients presenting with knee pain: Part I. History, physical examination, radiographs, and laboratory tests. Am Fam Physician. Sep 1 2003;68(5):907-12. [Medline].
Chandrashekar N, Mansouri H, Slauterbeck J, Hashemi J. Sex-based differences in the tensile properties of the human anterior cruciate ligament. J Biomech. 2006;39(16):2943-50. [Medline].
Christain EP. Extensor mechanism injuries of the knee. Top Emerg Med. 1995;17(2):25-35. [Medline].
Christian SR, Anderson MB, Workman R. Imaging of anterior knee pain. Clin Sports Med. Oct 2006;25(4):681-702. [Medline].
Davids JR. Pediatric knee. Clinical assessment and common disorders. Pediatr Clin North Am. Oct 1996;43(5):1067-90. [Medline].
Emparanza JI, Aginaga JR. Validation of the Ottawa Knee Rules. Ann Emerg Med. Oct 2001;38(4):364-8. [Medline].
Gupta A, Bodin L, Holmstrom B, Berggren L. A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg. Sep 2001;93(3):761-70. [Medline].
Ireland ML. The female ACL: why is it more prone to injury?. Orthop Clin North Am. Oct 2002;33(4):637-51. [Medline].
Jackson JL, O'Malley PG, Kroenke K. Evaluation of acute knee pain in primary care. Ann Intern Med. Oct 7 2003;139(7):575-88. [Medline].
Jacobson KE, Chi FS. Evaluation and treatment of medial collateral ligament and medial-sided injuries of the knee. Sports Med Arthrosc. Jun 2006;14(2):58-66. [Medline].
[Best Evidence] Karachalios T, Hantes M, Zibis AH. Diagnostic accuracy of a new clinical test (the Thessaly test) for early detection of meniscal tears. J Bone Joint Surg Am. May 2005;87(5):955-62. [Medline].
Karistinos A, Paulos LE. "Ciprofloxacin-induced" bilateral rectus femoris tendon rupture. Clin J Sport Med. Sep 2007;17(5):406-7. [Medline].
Munshi M, Davidson M, MacDonald PB, et al. The efficacy of magnetic resonance imaging in acute knee injuries. Clin J Sport Med. 2000;10(1):34-9. [Medline].
O'Shea KJ, Murphy KP, Heekin RD, Herzwurm PJ. The diagnostic accuracy of history, physical examination, and radiographs in the evaluation of traumatic knee disorders. Am J Sports Med. Mar-Apr 1996;24(2):164-7. [Medline].
Perryman JR, Hershman EB. The acute management of soft tissue injuries of the knee. Orthop Clin North Am. Jul 2002;33(3):575-85. [Medline].
Richman PB, McCuskey CF, Nashed A, et al. Performance of two clinical decision rules for knee radiography. J Emerg Med. Jul-Aug 1997;15(4):459-63. [Medline].
Robertson A, Nutton RW, Keating JF. Dislocation of the knee. J Bone Joint Surg Br. Jun 2006;88(6):706-11. [Medline].
Simon LV, Matteucci MJ, Tanen DA. The Pittsburgh Decision Rule: triage nurse versus physician utilization in the emergency department. J Emerg Med. Oct 2006;31(3):247-50. [Medline].
Solomon DH, Simel DL, Bates DW, et al. The rational clinical examination. Does this patient have a torn meniscus or ligament of the knee? Value of the physical examination. JAMA. Oct 3 2001;286(13):1610-20. [Medline].
Stannard JP, Sheils TM, Lopez-Ben RR, McGwin G Jr, Robinson JT, Volgas DA. Vascular injuries in knee dislocations: the role of physical examination in determining the need for arteriography. J Bone Joint Surg Am. May 2004;86-A(5):910-5. [Medline].
Twaddle BC, Bidwell TA, Chapman JR. Knee dislocations: where are the lesions? A prospective evaluation of surgical findings in 63 cases. J Orthop Trauma. Mar 2003;17(3):198-202. [Medline].
[Best Evidence] Wang CY, Wang HK, Hsu CY, Shieh JY, Wang TG, Jiang CC. Role of sonographic examination in traumatic knee internal derangement. Arch Phys Med Rehabil. Aug 2007;88(8):984-7. [Medline].
Further Reading
Keywords
soft tissue knee injury, soft-tissue knee injury, knee injury, knee pain, knee strain, knee ligaments, MCL, LCL, ACL, ACL tear, PCL, treatment, symptoms, diagnosis
Treatment & Medication: Knee Injury, Soft Tissue